Cargando…
Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension
AIM: Sacubitril/valsartan has been demonstrated to reduce blood pressure in hypertensive patients, but the best dose remains unclear. We performed this network meta-analysis to determine the comparative efficacy and safety of three available doses of sacubitril/valsartan (i.e., 100, 200, and 400 mg)...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293449/ https://www.ncbi.nlm.nih.gov/pubmed/36326841 http://dx.doi.org/10.1007/s00392-022-02120-0 |